Skip to main content
. 2022 Dec 20;12:1084683. doi: 10.3389/fonc.2022.1084683

Figure 3.

Figure 3

Impact of +1q on progression-free survival (PFS) and overall survival (OS) of patients with myeloma: Patients with +1q had shorter PFS and OS. (A). Progression-free survival. (B). Overall survival.